ScoreWhy is Hunan Jingfeng Pharmaceutical Co., Ltd. ?
1
- NET SALES(9M) At CNY 304.72 MM has Grown at -17.68%
- OPERATING CASH FLOW(Y) Lowest at CNY -2.75 MM
- PRE-TAX PROFIT(Q) At CNY -10.67 MM has Fallen at -125.44%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hunan Jingfeng Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hunan Jingfeng Pharmaceutical Co., Ltd.
62.15%
8.93
48.81%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-20.31%
EBIT Growth (5y)
14.30%
EBIT to Interest (avg)
-1.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
5.50
Sales to Capital Employed (avg)
0.98
Tax Ratio
3.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.30%
ROE (avg)
44.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
83.55
EV to EBIT
-140.26
EV to EBITDA
-777.52
EV to Capital Employed
9.99
EV to Sales
11.70
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
-7.12%
ROE (Latest)
303.13%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
NET PROFIT(HY)
Higher at CNY 247.96 MM
ROCE(HY)
Highest at 1,144.02%
INVENTORY TURNOVER RATIO(HY)
Highest at 3.01%
RAW MATERIAL COST(Y)
Fallen by -0.34% (YoY
-14What is not working for the Company
NET SALES(9M)
At CNY 304.72 MM has Grown at -17.68%
OPERATING CASH FLOW(Y)
Lowest at CNY -2.75 MM
PRE-TAX PROFIT(Q)
At CNY -10.67 MM has Fallen at -125.44%
NET PROFIT(Q)
At CNY -11.9 MM has Fallen at -131%
DEBT-EQUITY RATIO
(HY)
Highest at 561.01 %
Here's what is working for Hunan Jingfeng Pharmaceutical Co., Ltd.
Inventory Turnover Ratio
Highest at 3.01% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -0.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hunan Jingfeng Pharmaceutical Co., Ltd.
Net Sales
At CNY 304.72 MM has Grown at -17.68%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -10.67 MM has Fallen at -125.44%
over average net sales of the previous four periods of CNY 41.93 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -11.9 MM has Fallen at -131%
over average net sales of the previous four periods of CNY 38.38 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY -2.75 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at 561.01 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
